U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07939399) titled 'A Study of V951A in Healthy Participants (V951A-001)' on Nov. 10.
Brief Summary: This early study is testing an investigational vaccine called V951A. This study is looking for healthy volunteers. The main goals are to find out if the vaccine is safe, how well the human body handles different doses of it, and if it helps the body build immune defenses.
Study Start Date: Nov. 30
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
BIOLOGICAL: V951A
Administered via intramuscular injection.
OTHER: Placebo
Administered via intramuscular injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Merck Sharp &...